LITHOBID is a Oral Tablet, Film Coated, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Ani Pharmaceuticals, Inc.. The primary component is Lithium Carbonate.
| Product ID | 62559-280_37f8949f-f3f0-4f1a-8a21-4f940fbadf6d |
| NDC | 62559-280 |
| Product Type | Human Prescription Drug |
| Proprietary Name | LITHOBID |
| Generic Name | Lithium Carbonate |
| Dosage Form | Tablet, Film Coated, Extended Release |
| Route of Administration | ORAL |
| Marketing Start Date | 2014-07-01 |
| Marketing Category | NDA / NDA |
| Application Number | NDA018027 |
| Labeler Name | ANI Pharmaceuticals, Inc. |
| Substance Name | LITHIUM CARBONATE |
| Active Ingredient Strength | 300 mg/1 |
| Pharm Classes | Mood Stabilizer [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2014-07-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA018027 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2014-07-01 |
| Ingredient | Strength |
|---|---|
| LITHIUM CARBONATE | 300 mg/1 |
| SPL SET ID: | f7f5b69a-c2a1-4586-a189-1475d41387c0 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 62559-280 | LITHOBID | LITHOBID |
| 0054-0020 | Lithium Carbonate | Lithium Carbonate |
| 0054-0021 | Lithium Carbonate | Lithium Carbonate |
| 0054-2526 | Lithium Carbonate | Lithium Carbonate |
| 0054-2527 | Lithium Carbonate | Lithium Carbonate |
| 0054-2531 | Lithium Carbonate | Lithium Carbonate |
| 0054-4527 | Lithium Carbonate | Lithium Carbonate |
| 0054-8526 | Lithium Carbonate | Lithium Carbonate |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() LITHOBID 73219510 1147470 Live/Registered |
Rowell Laboratories, Inc. 1979-06-13 |